Corrinne Burns

Royal Pharmaceutical Society Correspondent

Corrinne Burns is Royal Pharmaceutical Society Correspondent at The Pharmaceutical Journal.

Minimum age set for puberty blockers trial

To participate in the ‘PATHWAYS’ clinical trial, a modified protocol has ruled that birth-registered females must be aged between 11 and 16 years, and birth-registered males must be aged between 12 and 16 years.…

Pharmacy regulator warns against promotion of prescription weight-loss medicines

A notice has reminded businesses that they cannot advertise prescription-only medicines or prescription-only medical treatments to the public.…

Community pharmacy delivers more than 4.5 million flu vaccines in 2025/2026

NHS Business Services Authority data reveals that during the 2025/2026 flu season, the Midlands region delivered the most vaccinations through community pharmacy in England, with more than 860,000.…

Branded medicines levy cut under statutory scheme

The Department of Health and Social Care said that the new 16.5% levy, a fall from the previous year’s 24.3%, will take effect from 1 July 2026.…

GPhC chair among pharmacists celebrated in King’s Birthday Honours

Gisela Abbam, chair of the General Pharmaceutical Council, has been recognised for her services to pharmacy.…

The Critical Medicines Act: can the UK manage supply problems with the EU’s ‘safety belt’?

Pharmacy leaders are hopeful that the Critical Medicines Act will help to alleviate medicines shortages in the UK, which have been rumbling on for several years.…

NICE approves seladelpar for primary biliary cholangitis

Around 3,700 people in England will be eligible to receive a new treatment that could delay progression of primary biliary cholangitis and reduce itching.…

PDA warns of ‘concerning’ decline in community pharmacists per pharmacy

The number of full-time equivalent pharmacists working in community pharmacy has reduced from 20,255 in 2021 to 17,415 in 2025, a PDA report says.…

Pharmacy minister praises ‘strategic thinking’ on community pharmacy reform

Speaking at a Westminster Hall debate, Stephen Kinnock thanked Community Pharmacy England for its "constructive engagement" on long term reform of community pharmacy.…

Tezepelumab may reduce need for oral corticosteroids in severe asthma

Study authors said their results “show the potential of tezepelumab to reduce maintenance oral corticosteroid use while maintaining asthma control and without compromising the efficacy outcomes”.…